rhIL-15 (human interleukin-15)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rhIL-15 (human interleukin-15), covering 2022-03-10 to 2022-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia [Phase 1]